Man Group »

Werewolf Therapeutics shares owned by Man Group

Quarter-by-quarter ownership of Werewolf Therapeutics (HOWL) shares owned by Man Group from 13F filings

Historical chart of Man Group investment in Werewolf Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Werewolf Therapeutics held by Man Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Werewolf Therapeutics by Man Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $516k 80k 6.48
2023-03-31 $117k 45k 2.60

More positions owned by Man Group

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Meta Platforms Cl A (META)
Qualcomm (QCOM)
Alphabet Cap Stk Cl C (GOOG)
Coca-Cola Company (KO)
Mastercard Incorporated Cl A (MA)
Equinix (EQIX)
Micron Technology (MU)
Merck & Co (MRK)

View all positions for Man Group

Top funds holding Werewolf Therapeutics

RA Capital Management
MPM Asset Management
Partner Fund Management
Adage Capital Partners GP
MPM Oncology Impact Management
Bank of America Corporation
Henderson Group
Rubric Capital Management
Vanguard Group
Monashee Investment Management
Eagle Health Investments
Sphera Funds Management
DC Funds
Verition Fund Management
Millennium Management

View all funds holding Werewolf Therapeutics